DH

David Hainsworth

Algorae Pharmaceuticals Limited | Executive Chairman, Executive Director, Interim CEO
Mr Hainsworth is a finance professional with more than 20 years experience in capital markets. His expertise extends to corporate financing and capital raising, with a specialisation in early-stage projects in the biotechnology industry.

Company and Roles

Company
Title
Tenure
Since
1AI
Algorae Pharmaceuticals Limited
  • Executive Chairman
  • Executive Director
  • Interim CEO
1yrs, 6mthJan 2023

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
1AI
Algorae Pharmaceuticals Limited
28/12/2320,000,0005,625,000312,500N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
1AI
Algorae Pharmaceuticals Limited
22/02/24
Cancelled
20,000,000$0.012$240,000Cancellation of securities
1AI
Algorae Pharmaceuticals Limited
28/12/23
Exercise
10,000,000$0.011$110,000Conversion of securities
1AI
Algorae Pharmaceuticals Limited
28/12/23
Buy
10,000,000$0.011$110,000Conversion of securities
1AI
Algorae Pharmaceuticals Limited
09/11/23
Buy
10,000,000$0.013$130,000Conversion of securities
1AI
Algorae Pharmaceuticals Limited
09/11/23
Exercise
10,000,000$0.013$130,000Conversion of securities